CAMBIO DE DISCURSO : LA SEGUNDA LINEA SMALL CELL LUNG CANCER EXTENSIVE-STAGE TRAS EL FIASCO DE LA FASE III LAGOON YA MEJOR NI NOMBRARLA ... CAMBIAMOS DISCURSO A MANTENIMIENTO EN PRIMERA LINEA Y PASAMOS DEL VIAL DE 4 Mg AI VIAL DE 2 Mg . ////. ESPERAMOS DECISIÓN DE JAZZPHARMA O BIEN LA DECISIÓN DE LA FDA TEMA SEGUNDA LÍNEA EEUU .////. 2 DE OCTUBRE DE 2028 ... ES LA FECHA MÁS TEPMPRANA PARA LA POSIBLE ENTRADA DE GENÉRICOS .
30 diciembre 2021
Adolfo García Sastre . Cada Vez Habla Más Claro : " EL COVID SE HA ACABADO " . " UN ASINTOMÁTICO TIENE EL VIRUS PERO NO COVID ". LA PANDEMIA ACABARÁ ANTES DE QUE LA OMS LA CONSIDERE ACABADA » .
Grifols, S.A. (NASDAQ:GRFS) Given Consensus Rating of "Hold" by Analysts .
December 30th, 2021 by MarketBeat .
Several Research Analysts have recently commented on GRFS shares. Deutsche Bank Aktiengesellschaft lowered Grifols from a "buy" rating to a "hold" rating in a research report on Thursday, November 4th. Citigroup upgraded Grifols from a "neutral" rating to a "buy" rating in a research report on Wednesday, October 6th. Barclays lowered Grifols from an "overweight" rating to an "underweight" rating in a research report on Tuesday, October 19th. Finally, Zacks Investment Research upgraded Grifols from a "sell" rating to a "hold" rating in a research report on Wednesday, November 17th. ...